Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

15 Voluntary ex ante Transparency (VEAT) Notice

OraSure, OraQuick Hepatitis C antibody, Point of Care Test

  • First published: 17 March 2023
  • Last modified: 17 March 2023

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-kuma6s-130063
Published by:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Authority ID:
AA0221
Publication date:
17 March 2023
Deadline date:
-
Notice type:
15 Voluntary ex ante Transparency (VEAT) Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
No

Abstract

OraSure, OraQuick Hepatitis C antibody, Point of Care test CPV: 38912000.

Full notice text

Voluntary ex ante transparency notice

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

NHS Wales Shared Services Partnership

2 Capital Quarter, Tyndall Street

Cardiff

CF10 4BZ

UK

Contact person: Nadine Stokes

Telephone: +44 2920902253

E-mail: nadine.stokes@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://nwssp.nhs.wales/ourservices/procurement-services/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

OraSure, OraQuick Hepatitis C antibody, Point of Care Test

II.1.2) Main CPV code

38912000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

OraSure, OraQuick Hepatitis C antibody, Point of Care test

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 180 000.00  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UKL


Main site or place of performance:

All Wales

II.2.4) Description of the procurement

OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation:

The OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity.

There are no alternative suppliers who have the CE marked technology for the OraQuick HCV rapid antibody test.

As such, there are no identified alternative suppliers who can complete all of the following elements as one test:

- The OraQuick HCV rapid antibody test plus absorbent packet

- An OraQuick HCV developer solution (0.75ml phosphate buffered saline solution containing polymers and a antimicrobial agent)

- Reusable test stands

- Collection loops

- Package insert

- Rapid HCV results ready in 20-40 minutes

- The OraQuick HCV test comes with quality control reagents include:

- When each new operator is using the kit

- Whenever a new test it lot is opened

- Whenever the kit storage area falls outside of 2C-30C

- Whenever the kit testing area fall outside of 15C-37C

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section V: Award of contract/concession

V.2 Award of contract/concession

V.2.1) Date of conclusion of the contract/concession

16/03/2023

V.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Invitech Ltd

Unit 4, Molesworth Business Estate, Molesworth

Huntingdon

PE280QG

UK

Telephone: +44 8453133348

Fax: +44 8453133349

NUTS: UKH12

The contractor is an SME: No

V.2.4) Information on value of the concession and main financing terms (excluding VAT)

Initial estimated total value of the contract/lot/concession: 180 000.00 GBP

Total value of the concession/lot: 180 000.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.

(WA Ref:130063)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

NHS Wales Shared Services Partnership on behalf of Public Health Wales NHS Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.

Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful.

Should additional information be required it should be requested of the addressee in section I.1.

Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015

VI.5) Date of dispatch of this notice

17/03/2023

Coding

Commodity categories

ID Title Parent category
38912000 Automated swab test kits Hygiene monitoring and testing equipment

Delivery locations

ID Description
1017 Bridgend and Neath Port Talbot
1022 Cardiff and Vale of Glamorgan
1015 Central Valleys (Merthyr Tydfil, Rhondda Cynon Taf)
1013 Conwy and Denbighshire
1020 East Wales
1023 Flintshire and Wrexham
1016 Gwent Valleys (Torfaen, Blaenau Gwent, Caerphilly)
1012 Gwynedd
1011 Isle of Anglesey
1021 Monmouthshire and Newport
1024 Powys
1014 South West Wales (Carmarthenshire, Pembrokeshire, Ceredigion)
1018 Swansea
1000 WALES
1010 West Wales and The Valleys

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

Document family

Notice details
Publication date:
17 March 2023
Notice type:
15 Voluntary ex ante Transparency (VEAT) Notice
Authority name:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Publication date:
04 May 2023
Notice type:
03 Contract Award Notice - Successful Supplier(s)
Authority name:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

About the buyer

Main contact:
nadine.stokes@wales.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.